InvestorsHub Logo
Followers 3
Posts 288
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Thursday, 03/23/2023 3:33:15 PM

Thursday, March 23, 2023 3:33:15 PM

Post# of 3283
Mar. 23, 2023, 10:15 AM
Jefferies analyst Maury Raycroft maintained a Buy rating on Spectrum Pharmaceuticals (SPPI – Research Report) yesterday and set a price target of $3.50. The company’s shares opened today at $0.73.